1 May, 2018
In May 2018 Sensius established an Advisory Board with board members with specific knowledge and experience on financing of startups, marketing and sales and a large global network within the field of oncology. Therefore, we are very happy to announce that Michel Rudolphie and Reender Beks, people with a strong connection to the working fields of Sensius, have accepted being a member or our Board of Advice.
Michel Rudophie, member of the board of directors of the Lygature foundation, a foundation with a focus on providing medical innovations to people with medical needs all over the world. Rudolphie is also former-director of the Dutch Cancer Society (KWF Kankerbestrijding):
“Sensius is adding value in cancer care by redefining thermotherapy. Through intense focus and real time control Sensius is able to provide a new standard for treating cancer patients and improving quality of life. Sensius fully understand the patient needs and speaks the language of the health care providers. A successful combination benefitting the cancer patient.”
Reender Beks, former CFO of Sapiens and now CFO of Forcare:
“The Sensius team shares a great passion to defeat cancer and, with a wealth of experience in this field, demonstrates that a novel technology in the form of thermotherapy can significantly contribute to the well-being of patients during the stressful times of radiation and chemo, as many publications show evidence that this therapy can significantly reduce the probability of recurrence of the disease. With a strong value proposition that complements existing treatment modalities, Sensius has the opportunity to vastly expand a market that is yet in its early childhood stage.”
Want to know more? Please do not hesitate to contact us: contact